In the news | 2nd Aug 2022
Approaching the BioPharma data lifecycle in an integrated manner
Advances in digital technology offer an attractive solution to biopharmaceutical companies looking to deliver a new generation of increasingly complex therapies. While artificial intelligence and automation such as the Industry 4.0 movement have the potential to reduce time and cost, modernized data governance is essential to ensure a solid foundation of data integrity and regulatory compliance to meet these objectives.
Read about an integrated approach to the BioPharma data lifecycle in this article by Scott Weiss, Vice President of Business Development and Open Innovation, IDBS, published in PharmTech.com.
How to get more insight and value out of your Electronic Batch Record data with PIMS
Discover how PIMS can work synergistically with your existing Electronic Batch Record (EBR) software and why PIMS is a great alternative.
New process definition capabilities in PIMS further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Tradeshow | European BioAnalysis Forum | Nov 2023
Speak to our experts to learn how an innovative approach to transform your bioanalytical operations and to improve data quality, productivity and compliance, according to industry standards such as ICH M10 standards
Software validation keeps GxP systems current and speeds up time-to-market
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.